Harvey George Roweth, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Platelets | 12 | 2024 | 2520 | 1.810 |
Why?
|
Megakaryocytes | 4 | 2024 | 565 | 1.790 |
Why?
|
Citalopram | 2 | 2018 | 402 | 1.000 |
Why?
|
Platelet Aggregation | 3 | 2018 | 805 | 0.990 |
Why?
|
Angiopoietin-1 | 1 | 2024 | 122 | 0.910 |
Why?
|
Hemostasis | 2 | 2023 | 468 | 0.700 |
Why?
|
Lymphatic Vessels | 1 | 2023 | 358 | 0.620 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 749 | 0.620 |
Why?
|
Neovascularization, Pathologic | 3 | 2024 | 2640 | 0.570 |
Why?
|
Thrombopoiesis | 1 | 2018 | 164 | 0.550 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2018 | 324 | 0.530 |
Why?
|
Neoplasms | 5 | 2023 | 22072 | 0.470 |
Why?
|
Serotonin | 1 | 2018 | 1040 | 0.430 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3844 | 0.360 |
Why?
|
Thrombocytopenia | 1 | 2018 | 1174 | 0.360 |
Why?
|
Mice, Knockout | 2 | 2024 | 14372 | 0.340 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2022 | 3201 | 0.340 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3610 | 0.320 |
Why?
|
Neutrophils | 1 | 2018 | 3767 | 0.260 |
Why?
|
Cathepsin G | 1 | 2022 | 31 | 0.210 |
Why?
|
Neoplasm Metastasis | 3 | 2023 | 4902 | 0.210 |
Why?
|
Centrosome | 1 | 2024 | 207 | 0.210 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2024 | 507 | 0.190 |
Why?
|
Melanoma, Experimental | 1 | 2024 | 562 | 0.190 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13262 | 0.170 |
Why?
|
Platelet Count | 2 | 2022 | 777 | 0.170 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2018 | 65 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 1 | 2022 | 459 | 0.160 |
Why?
|
Tumor Burden | 1 | 2024 | 1895 | 0.150 |
Why?
|
Thromboxane A2 | 1 | 2018 | 90 | 0.150 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2018 | 285 | 0.150 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2018 | 412 | 0.150 |
Why?
|
Cell Cycle | 1 | 2024 | 2934 | 0.130 |
Why?
|
Neovascularization, Physiologic | 1 | 2023 | 1336 | 0.130 |
Why?
|
Flavones | 1 | 2015 | 68 | 0.130 |
Why?
|
Cytosol | 1 | 2018 | 887 | 0.130 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18137 | 0.120 |
Why?
|
Animals | 7 | 2024 | 167963 | 0.110 |
Why?
|
Cytoskeleton | 1 | 2018 | 1167 | 0.110 |
Why?
|
Mice | 4 | 2024 | 81208 | 0.100 |
Why?
|
Rabbits | 1 | 2018 | 4773 | 0.100 |
Why?
|
Aspirin | 2 | 2022 | 3364 | 0.090 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 16939 | 0.090 |
Why?
|
Gene Expression | 1 | 2022 | 7588 | 0.080 |
Why?
|
Calcium | 2 | 2018 | 5725 | 0.080 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22023 | 0.070 |
Why?
|
Phosphorylation | 1 | 2018 | 8313 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3600 | 0.070 |
Why?
|
Platelet Activation | 2 | 2022 | 660 | 0.060 |
Why?
|
Humans | 11 | 2024 | 760621 | 0.060 |
Why?
|
Models, Biological | 1 | 2018 | 9467 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 695 | 0.040 |
Why?
|
Mitosis | 1 | 2024 | 1191 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2019 | 2448 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23376 | 0.040 |
Why?
|
Blood Coagulation Tests | 1 | 2015 | 270 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3157 | 0.030 |
Why?
|
Cyclic GMP | 1 | 2015 | 395 | 0.030 |
Why?
|
Leukocytes | 1 | 2022 | 2026 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1933 | 0.030 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2015 | 638 | 0.030 |
Why?
|
Fibrinogen | 1 | 2015 | 886 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21025 | 0.020 |
Why?
|
Female | 2 | 2024 | 391270 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11152 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7343 | 0.010 |
Why?
|
Thrombosis | 1 | 2015 | 3052 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18957 | 0.010 |
Why?
|
United States | 1 | 2022 | 72461 | 0.010 |
Why?
|